Gem Aromatics Makes a Muted Debut on Stock Market, Shares List at 2.49% Premium

Gem Aromatics Ltd launched its Initial Public Offering (IPO) on August 19, 2025. The bidding window for the IPO was open till August 21, 2025, for public subscription. The shares of Gem Aromatics made a flat debut on the Dalal Street today, on August 26, 2025, listing at a slight premium over its issue price on both NSE and BSE. 

The shares of Gem Aromatics Ltd made a flat listing at ₹325 on the BSE, marking a 0% premium over the IPO price band of ₹325. However, the shares listed at ₹333.10 on the NSE showed a slight premium of 2.49% over the IPO issue price.

Overall, the Gem Aromatics listing was below the grey market expectations. Ahead of the listing, unlisted shares of the company were trading at ₹358, hinting at a listing at a 10.15% premium.

Gem Aromatics IPO Overall Subscription Status

(August 21, 2025, 7 PM )

On Day 3, Gem Aromatics IPO saw a subscription of 30.27 times. The public issue was subscribed 10.31 times by the Retail Individual Investors (RIIs), 45.06 times by the Non-Institutional Investors and 55.28 times by the Qualified Institutional Buyers (QIBs).

Check out newly Listed IPOs on BSE and NSE.

IPO Details 

Gem Aromatics IPO is a bookbuilding of ₹451.25 crores. The issue is a combination of fresh issue of 0.54 crore shares aggregating to ₹175.00 crores and offer for sale (OFS) of 0.85 crore shares aggregating to ₹276.25 crores.

The IPO price band is set between ₹309 and ₹325, and the minimum lot size for an application is 46. The minimum investment amount required for retail investors is ₹14,214 (46 shares).

Motilal Oswal Investment Advisors Ltd. is the book running lead manager, and Kfin Technologies Ltd. is the registrar of the issue.

Explore other Upcoming IPOs on BSE and NSE.

Gem Aromatics Ltd - Business Overview

Gem Aromatics Limited, founded in 1997, is a leading Indian manufacturer of essential oils, aroma chemicals, and specialty ingredients. The company serves industries such as flavours, fragrances, personal care, nutraceuticals, and pharmaceuticals.

The company supplies to reputed FMCG companies like Colgate-Palmolive, Dabur, and Patanjali. It also has a subsidiary in the U.S. for distribution, strengthening its international presence.

The company has shown consistent growth, with revenues rising from ₹424.79 crore in FY23 to ₹503.95 crore in FY25, and profits increasing from ₹44.67 crore to ₹53.38 crore in the same period.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.